4//SEC Filing
RUCH JOSHUA 4
Accession 0001209191-23-053012
CIK 0001818331other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:49 PM ET
Size
10.2 KB
Accession
0001209191-23-053012
Insider Transaction Report
Form 4
RUCH JOSHUA
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-10-15−129→ 130 total→ Class A Common Stock (129 underlying) - Exercise/Conversion
Class A Common Stock
2023-10-15+129→ 2,025 total
Holdings
- 149,283(indirect: By VAAL Investment Partners Q9 LP)
Class A Common Stock
- 30,137(indirect: By LLC)
Class A Common Stock
- 14,844(indirect: By LLC)
Class A Common Stock
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]Mr. Ruch is (i) a managing member of the managing member of the general partner of Vaal Investment Partners Q9 LP ("Q9"), (ii) a managing member of RUGU2 LLC ("RUGU2") and (iii) a managing member of Kariba LLC ("Kariba"). As such, Mr. Ruch exercises voting and investment power with respect to the shares owned by Q9, RUGU2 and Kariba. Mr. Ruch disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- [F3]The RSUs will vest in equal annual installments over the three-year period following the grant date of October 15, 2021, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0000943431
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:49 PM ET
- Size
- 10.2 KB